Formulation and Evaluation of Olanzapine Oral Lyophilisates

Authors

  • Rasha Khalid Dhahir
  • Fadia yassir Al-bazzaz
  • Myasar Al-kotaji
  • Mutasem Rawas-Qalaji

Keywords:

Olanzapine, oral lyophilisates, rapidly disintegrating tablet, freeze drying

Abstract

One of the main obstacles to the development and delivery of drugs is poor drug solubility. Lyophilization is one of the common techniques that has been utilized to formulate alternative solid dosage forms that has the potential to improve drug delivery. In the present work, Olanzapine was manufactured using this technique to develop convenient and easy-to-administer rapidly disintegrating tablets as oral lyophilisates for the treatment of psychotic disorders.
By dispersing the medication in an aqueous solution of mannitol, MCC, various binders, and glycine, various formulations of Olanzapine oral lyophilisates were prepared. By assessing the hardness, disintegration time, wetting time, and dissolution time, the effect of mannitol, MCC, and various binders on the oral lyophilisates' properties was investigated. Furthermore, FTIR, DSC, and SEM were used to further characterize the produced oral lyophilisates.
The formed Olanzapine oral lyophilisates resulted in rapid tablet disintegration (11.6 to 23.5 sec) and a drug dissolution of 48.7% to 77.7% within two minutes. The FTIR spectra showed no drug-excipient interactions, while the DSC and SEM results show the crystalline state of Olanzapine in the pure drug and the physical mixture and there is clear evidence of transformation to the amorphous state during the formation of the oral lyophlisates. To conclude, this work succeeded in production of Olanzapine oral lyophilisates (Formula 7) with rapid disintegration, rapid dissolution and with no evidence for drug-excipient interactions.

Author Biographies

Rasha Khalid Dhahir

Department of Pharmaceutics, College of Pharmacy, University of Mosul, Mosul, Iraq,

Fadia yassir Al-bazzaz

Department of Pharmaceutics, College of Pharmacy, University of Mosul, Mosul, Iraq,

Myasar Al-kotaji

Department of Pharmaceutics, College of Pharmacy, Ninevah University, Mosul, Iraq,

Mutasem Rawas-Qalaji

College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.

References

Anup N., Thakkar S., Misra M. Formulation of olanzapine nanosuspension based orally disintegrating tablets (ODT); comparative evaluation of lyophilization and electrospraying process as solidification techniques. Adv. Powder Technol. 29(8),1913–24, 2018.

Montgomery B., Treuer., Karagianis., Ascher-Svanum H., Harrison. Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties. Patient Prefer. Adherence. 6.109-125, 2012.

Ravi S., Rudrangi S., Trivedi V., Mitchell JC., Wicks SR., Alexander BD. Preparation of olanzapine and methyl- b -cyclodextrin complexes using a single-step , organic solvent-free supercritical fl uid process : An approach to enhance the solubility and dissolution properties. Int. J. Pharm. 494(1), 408–16, 2015.

Hooper P., Lasher J., Alexander KS., Baki G. Journal of Pharmaceutical and Biomedical Analysis A new modified wetting test and an alternative disintegration test for orally disintegrating tablets. J. Pharm. Biomed. Anal. 120, 391–6, 2016.

Iurian S., Tomu I., Szabó-révész P., Chvatal A., Leucu SE., Moldovan M., et al. European Journal of Pharmaceutical Sciences Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach. 104, 356–65, 2017.

de Haan L., van Amelsvoort T., Rosien K., Linszen D. Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets. Psychopharmacology (Berl). 175, 389–90, 2004.

Girault E.M., Alkemade A., Foppen E., Ackermans M. T., Fliers. E., Kalsbeek A. Acute peripheral but not central administration of olanzapine induces hyperglycemia associated with hepatic and extra-hepatic insulin resistance. PLOS ONE. 7(8), 43244, 2012.

Abed K.K., Hussein A.A., Ghareeb M.M., Abdulrasool A.A. Formulation and Optimization of Orodispersible Tablets of Diazepam. AAPS PharmSciTech. 11(1), 356–61, 2010.

Mahajan H.S., Kelkar Y.V. Journal of Drug Delivery Science and Technology Pregelatinized hydroxypropyl pea starch as matrix forming material for lyophilized orodispersible tablets of tadala fi l. J. Drug Deliv. Sci. Technol. 41, 310–6, 2017.

Al Ashmawy A.G, Eissa N.G., Nahas H.M. El., Balata G.F. Journal of Drug Delivery Science and Technology Fast disintegrating tablet of Doxazosin Mesylate nanosuspension : Preparation and characterization. J. Drug Deliv. Sci. Technol. 61,102210, 2021.

Salama A.H., Basha M., El S. Experimentally designed lyophilized dry emulsion tablets for enhancing the antihyperlipidemic activity of atorvastatin calcium : Preparation , in-vitro evaluation and in-vivo assessment. Eur. J .Pharm Sci. 112,52–62, 2018.

Vanbillemont B., De Beer T. Model-based optimization of the primary drying phase of oral lyophilizates. Int. J. Pharm. X. 2, 100057, Dec; 2020.

Stange U., Führling C., Gieseler H. Formulation, Preparation, and Evaluation of Novel Orally Disintegrating Tablets Containing Taste-Masked Naproxen Sodium Granules and Naratriptan Hydrochloride. J. Pharm. Sci. 103(4), 1233–45, 2014.

Nasser S.J., Sameen L.H,. Ghareeb M.M. Preparation and Evaluation of Oral Disintegrating Tablets of Ketoprofen by Dirct Compression. Iraqi J. Pharm. Sci .P-. 21(2), 63–8, 2017.

Rowe R.C. editor (2009) Handbook of pharmaceutical excipients. 6. ed. London: APhA, (PhP) Pharmaceutical Press.

Rus L.M. Development Of Meloxicam Oral Lyophilisates: Role Of Thermal Analysis And Complementary Techniques. FARMACIA. 67(1), 56–67,2019.

Rus L.M., Iurian S., Kacso I., Borodi G., Porav S. Hegheş S,C. Iuga C.A., Tomuţă I. Development of meloxicam oral lyophilisates : Role opf thermal analysis complementary techniques. Farmacia. 67(1), 57, 2019.

Dhahir R.K., Al-kotaji M. Preparation of Cinnarizine Oral Lyophilizates. Irq. J. Pharm. 18(1), 35, 2021.

Downloads

Published

03-04-2024

Issue

Section

Research Articles